Philip Clarke

A Patient-Level Model to Estimate Lifetime Health Outcomes of Patients With Type 1 Diabetes

An Tran-Duy, Josh Knight, Andrew J Palmer, Dennis Petrie, Tom WC Lung, William H Herman, Bjorn Eliasson, Ann-Marie Svensson, Philip M Clarke

Journal article  |  2020  |  Diabetes Care

OBJECTIVE: To develop a patient-level simulation model for predicting lifetime health outcomes of patients with type 1 diabetes an..

Patient-reported outcome measures (PROMs): can they be used to guide patient-centered care and optimize outcomes in total knee replacement?

Michelle Tew, Kim Dalziel, Philip Clarke, Anne Smith, Peter F Choong, Michelle Dowsey

Journal article  |  2020  |  Quality of Life Research

PURPOSE: As patient-reported outcome measures (PROMs) are increasingly integrated into clinical practice, there is a need to trans..

Effects of Allopurinol on the Progression of Chronic Kidney Disease

Sunil V Badve, Elaine M Pascoe, M Biostat, Anushree Tiku, Neil Boudville, Fiona G Brown, Alan Cass, Philip Clarke, Nicola Dalbeth, Richard O Day, Janak R de Zoysa, Bettina Douglas, Randall Faull, David C Harris, Carmel M Hawley, Graham RD Jones, John Kanellis, Suetonia C Palmer, Vlado Perkovic, Gopala K Rangan, et al.

Journal article  |  2020  |  New England Journal of Medicine

BACKGROUND: Elevated serum urate levels are associated with progression of chronic kidney disease. Whether urate-lowering treatmen..

CANCER RISK AND RESOURCE UTILIZATION FOR 5 COMMON CANCERS IN A MATCHED CHINESE DIABETES POPULATION OF 331,000 PATIENTS

N Wu, PM Clarke, A Palmer, B Cui, L Wang, M IJzerman

Conference Proceedings  |  2020  |  VALUE IN HEALTH

Accurately Reflecting Uncertainty When Using Patient-Level Simulation Models to Extrapolate Clinical Trial Data.

Helen A Dakin, José Leal, Andrew Briggs, Philip Clarke, Rury R Holman, Alastair Gray

Journal article  |  2020  |  Medical Decision Making

Introduction. Patient-level simulation models facilitate extrapolation of clinical trial data while allowing for heterogeneity, pr..

Group Testing for SARS-CoV-2: Forward to the Past?

Koen B Pouwels, Laurence SJ Roope, Adrian Barnett, David J Hunter, Terry M Nolan, Philip M Clarke

Journal article  |  2020  |  PharmacoEconomics - open

Group Testing for SARS-CoV-2: Forward to the Past?

Koen B Pouwels, Laurence SJ Roope, Adrian Barnett, David J Hunter, Terry M Nolan, Philip M Clarke

Journal article  |  2020  |  PHARMACOECONOMICS-OPEN

Exploring the Impact of Quality of Life on Survival: A Case Study in Total Knee Replacement Surgery

Michelle Tew, Kim Dalziel, Michelle Dowsey, Peter F Choong, Philip Clarke

Journal article  |  2020  |  Medical Decision Making

Background. There is growing evidence that quality of life (QoL) has a strong association with mortality. However, incorporation o..

Modelling the impact of multiple sclerosis on life expectancy, quality-adjusted life years and total lifetime costs: Evidence from Australia

Andrew J Palmer, Ingrid van der Mei, Bruce Taylor, Philip M Clarke, Steve Simpson, Hasnat Ahmad

Journal article  |  2020  |  Multiple Sclerosis Journal

OBJECTIVES: To quantify life expectancy (LE), quality-adjusted life years (QALYs) and total lifetime societal costs for a hypothet..

Attitudes of patients and surgeons towards sham surgery trials: a protocol for a scoping review of attributes to inform a discrete choice experiment

Laura Wall, Madeleine Hinwood, Danielle Lang, Angela Smith, Samantha Bunzli, Philip Clarke, Peter FM Choong, Michelle M Dowsey, Francesco Paolucci

Journal article  |  2020  |  BMJ OPEN

INTRODUCTION: In order to properly evaluate the efficacy of orthopaedic procedures, rigorous, randomised controlled sham surgery t..

Development and Use of Prediction Models for Classification of Cardiovascular Risk of Remote Indigenous Australians

A Tran-Duy, Robyn McDermott, Josh Knight, Xinyang Hua, Elizabeth LM Barr, Kerry Arabena, Andrew Palmer, Philip Clarke

Journal article  |  2020  |  Heart, Lung and Circulation

Background: Cardiovascular disease (CVD) is the leading cause of death for Indigenous Australians. There is widespread belief that..

Registered Reports: Time to Radically Rethink Peer Review in Health Economics

Philip Clarke, John Buckell, Adrian Barnett

Journal article  |  2020  |  PHARMACOECONOMICS-OPEN

Self-rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: findings from the ADVANCE and ADVANCE-ON trials

X Hua, TWC Lung, M Woodward, JA Salomon, P Hamet, SB Harrap, G Mancia, N Poulter, J Chalmers, PM Clarke

Journal article  |  2020  |  Diabetic Medicine

AIMS: To explore whether there is a different strength of association between self-rated health and all-cause mortality in people ..

Defining and measuring health poverty

Philip Clarke, Guido Erreygers

Journal article  |  2020  |  Social Science & Medicine

Unlike other aspects of welfare (e.g. income), health has been relatively neglected when it comes to defining and measuring aspect..

Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-labe 12-month, randomised controlled trial

John Furler, David O'Neal, Jane Speight, Irene Blackberry, Jo-Anne Manski-Nankervis, Sharmala Thuraisingam, Katie de La Rue, Louise Ginnivan, Rebecca Doyle, Elizabeth Holmes-Truscott, Kamlesh Khunti, Kim Dalziel, Jason Chiang, Ralph Audehm, Mark Kennedy, Malcolm Clark, Alicia Jenkins, Amelia J Lake, Andrzej S Januszewski, Max Catchpool, et al.

Journal article  |  2020  |  The Lancet Diabetes & Endocrinology

BACKGROUND: Continuous glucose monitoring, either real-time (personal) or retrospective (professional mode), can identify day-to-d..

The acceptability of using a lottery to allocate research funding: a survey of applicants.

Mengyao Liu, Vernon Choy, Philip Clarke, Adrian Barnett, Tony Blakely, Lucy Pomeroy

Journal article  |  2020  |  Res Integr Peer Rev

Background: The Health Research Council of New Zealand is the first major government funding agency to use a lottery to allocate r..

The Surgeon's Role in the Opioid Crisis: A Narrative Review and Call to Action

Cade Shadbolt, J Haxby Abbott, Ximena Camacho, Philip Clarke, L Stefan Lohmander, Tim Spelman, Eric C Sun, Jonas B Thorlund, Yuting Zhang, Michelle M Dowsey, Peter FM Choong

Journal article  |  2020  |  Frontiers in Surgery

Over the past two decades, there has been a sharp rise in the use of prescription opioids. In several countries, most notably the ..

Co-Morbidities and Sex Differences in Long-Term Quality-of-Life Outcomes among Patients with and without Diabetes after Total Knee Replacement: Five-Year Data from Registry Study

Michelle Tew, Michelle M Dowsey, Annabelle Choong, Peter F Choong, Philip Clarke

Journal article  |  2020  |  Journal of Clinical Medicine

Improved understanding of quality-of-life (QoL) outcomes can provide valuable information on intervention effectiveness and guide ..

The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood

Seamus Kent, Frauke Becker, Talitha Feenstra, Tran-Duy An, Iryna Schlackow, Michelle Tew, Ping Zhang, Wen Ye, Lizheng Shi, William Herman, Phil McEwan, Wendelin Schramm, Alastair Gray, Jose Leal, Mark Lamotte, Michael Willis, Andrew J Palmer, Philip Clarke

Journal article  |  2019  |  PharmacoEconomics

Transparency in health economic decision modelling is important for engendering confidence in the models and in the reliability of..

Estimation of annual probabilities of changing disability levels in Australians with relapsing-remitting multiple sclerosis

Hasnat Ahmad, Ingrid van der Mei, Bruce Taylor, Robyn M Lucas, Anne-Louise Ponsonby, Jeannette Lechner-Scott, Keith Dear, Patricia Valery, Philip M Clarke, Steve Simpson, Andrew J Palmer, Terry Dwyer, Leigh Blizzard, Simon Broadley, Trevor Kilpatrick, David Williams, Jeanette Lechner-Scott, Cameron Shaw, Caron Chapman, Alan Coulthard, et al.

Journal article  |  2019  |  Multiple Sclerosis Journal

BACKGROUND: Transition probabilities are the engine within many health economics decision models. However, the probabilities of pr..

Multicentre randomised double-blind placebo controlled trial of combination vancomycin and cefazolin surgical antibiotic prophylaxis: the Australian surgical antibiotic prophylaxis (ASAP) trial

Trisha Peel, Sarah Astbury, Allen C Cheng, David Paterson, Kirsty Buising, Tim Spelman, Tran-Duy An, Richard S de Steiger, Peter Choong, Allen Cheng, David Paterson, Kirsty Buising, Michelle Dowsey, Ross Crawford, Tim Spelman, Philip Clarke, Ben Howden, Peter Rehfisch, Robert Molnar, Sam Adie, et al.

Journal article  |  2019  |  BMJ Open

INTRODUCTION: Resistant Gram-positive organisms, such as methicillin-resistant staphylococci, account for a significant proportion..

Transparency in Decision Modelling: What, Why, Who and How?

Christopher James Sampson, Renée Arnold, Stirling Bryan, Philip Clarke, Sean Ekins, Anthony Hatswell, Neil Hawkins, Sue Langham, Deborah Marshall, Mohsen Sadatsafavi, Will Sullivan, Edward CF Wilson, Tim Wrightson

Journal article  |  2019  |  PharmacoEconomics

Transparency in decision modelling is an evolving concept. Recently, discussion has moved from reporting standards to open-source ..

Opioid use prior to elective surgery is strongly associated with persistent use following surgery: an analysis of 14 354 Medicare patients

Max Catchpool, Josh Knight, Jesse T Young, Philip Clarke, Michael J Barrington, Peter FM Choong, Michelle M Dowsey

Journal article  |  2019  |  ANZ JOURNAL OF SURGERY

BACKGROUND: Persistent opioid use following total joint replacement (TJR) surgery is common; however, the association between pre-..

Primary Prevention of Cardiovascular Disease in Minority Indigenous Populations: A Systematic Review.

Lea Merone, Robyn McDermott, Jacki Mein, Philip Clarke, Malcolm McDonald

Journal article  |  2019  |  Heart, Lung and Circulation

INTRODUCTION: Cardiovascular disease (CVD) is the commonest cause of death across the globe; incidence and prevalence rates are in..

F3-04-03: STAKEHOLDER PERSPECTIVES ON HOW THE HOME CARE SECTOR CAN SUPPORT PEOPLE TO LIVE WELL WITH DEMENTIA

Anita MY Goh, Briony Dow, Meg Polacsek, Colleen Doyle, David Ames, Margaret Winbolt, Steven Savvas, Susan Malta, Lee-Fay Low, Philip Clarke, Claudia Cooper, Anita Panayiotou, Gill Livingston, Constantine Lyketsos, Luke Gahan, Frances Batchelor, Samantha M Loi, Jason Burton, Brendan Hallam, Sam Scherer, et al.

Conference Proceedings  |  2019  |  Alzheimer's & Dementia

Incorporating Future Medical Costs: Impact on Cost-Effectiveness Analysis in Cancer Patients

Michelle Tew, Philip Clarke, Karin Thursky, Kim Dalziel

Journal article  |  2019  |  PharmacoEconomics

MODELLING PROGRESSION OF RISK FACTORS IN PATIENTS WITH TYPE 1 DIABETES: TOWARDS THE MOST APPROPRIATE FUNCTIONAL FORMS FOR A SIMULATION MODEL OF LONG-TERM HEALTH OUTCOMES

A Tran-Duy, J Knight, AJ Palmer, B Eliasson, AM Svensson, PM Clarke

Conference Proceedings  |  2019  |  Value in Health

IMPACT OF COMORBID CONDITIONS ON HEALTH CARE EXPENDITURE AND WORK-RELATED OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS: A RETROSPECTIVE ANALYSIS USING THE MEDICAL EXPENDITURE PANEL SURVEY IN THE PERIOD 2006-2015

MV Vu, N Carvalho, R Buchbinder, G McColl, PM Clarke, A Tran-Duy

Conference Proceedings  |  2019  |  Value in Health

The impact of Medicare part D on income-related inequality in pharmaceutical expenditure

Natalie Carvalho, Dennis Petrie, Linkun Chen, Joshua A Salomon, Philip Clarke

Journal article  |  2019  |  International Journal for Equity in Health

Excess Burden of Mental Illness and Hospitalization in Young-Onset Type 2 Diabetes: A Population-Based Cohort Study.

Calvin Ke, Eric Lau, Baiju R Shah, Thérèse A Stukel, Ronald C Ma, Wing-Yee So, Alice P Kong, Elaine Chow, Philip Clarke, William Goggins, Juliana CN Chan, Andrea Luk

Journal article  |  2019  |  Annals of Internal Medicine

Background: Type 2 diabetes (T2D) increases hospitalization risk. Young-onset T2D (YOD) (defined as onset before age 40 years) is ..

DRIVEN TO HYPERGLYCAEMIA: ADULTS WITH TYPE 1 DIABETES HAVE HIGHER GLUCOSE LEVELS WHEN DRIVING

S Trawley, S McAuley, M Lee, B Paldus, L Bach, M Burt, P Clarke, N Cohen, P Colman, M Debock, C Hendrieckx, D Holmes-Walker, A Jenkins, J Kaye, A Keech, K Kumareswaran, R Macisaac, R McCallum, C Sims, J Speight, et al.

Conference Proceedings  |  2019  |  DIABETES TECHNOLOGY & THERAPEUTICS

GLUCOSE TIME-IN-RANGE AFTER TYPE 1 DIABETES EDUCATION IS NOT DIFFERENT BETWEEN ADULTS USING INSULIN PUMPS AND MULTIPLE DAILY INJECTIONS

S McAuley, S Vogrin, M Lee, B Paldus, L Bach, M Burt, P Clarke, N Cohen, P Colman, M de Bock, C Hendrieckx, D Holmes-Walker, J Horsburgh, A Jenkins, J Kaye, A Keech, K Kumareswaran, R MacIsaac, R McCallum, C Sims, et al.

Conference Proceedings  |  2019  |  DIABETES TECHNOLOGY & THERAPEUTICS

Health system costs for individual and comorbid noncommunicable diseases: An analysis of publicly funded health events from New Zealand

Tony Blakely, Giorgi Kvizhinadze, June Atkinson, Joseph Dieleman, Philip Clarke

Journal article  |  2019  |  PLOS Medicine

Background There is little systematic assessment of how total health expenditure is distributed across diseases and comorbidities...

Accuracy of patient recall for self-reported doctor visits: Is shorter recall better?

Kim Dalziel, Jinhu Li, Anthony Scott, Philip Clarke

Journal article  |  2018  |  Health Economics

An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity Results From a Pragmatic Open-Label Trial

An Tran-Duy, Marjan Ghiti Moghadam, Martijn AH Oude Voshaar, Harald E Vonkeman, Annelies Boonen, Philip Clarke, Geoff McColl, Peter M ten Klooster, TR Zijlstra, Willem F Lems, N Riyazi, EN Griep, JMW Hazes, Robert Landewe, Hein J Bernelot Moens, Piet LCM van Riel, Mart AFJ van de Laar, TL Jansen

Journal article  |  2018  |  Arthritis and Rheumatology

GP-OSMOTIC trial protocol: an individually randomised controlled trial to determine the effect of retrospective continuous glucose monitoring (r-CGM) on HbA1c in adults with type 2 diabetes in general practice

John Furler, David Norman O'Neal, Jane Speight, Irene Blackberry, Jo-Anne Manski-Nankervis, Sharmala Thuraisingam, Katie de La Rue, Louise Ginnivan, Jessica Lea Browne, Elizabeth Holmes-Truscott, Kamlesh Khunti, Kim Dalziel, Jason Chiang, Ralph Audehm, Mark Kennedy, Malcolm Clark, Alicia Josephine Jenkins, Danny Liew, Philip Clarke, James Best

Journal article  |  2018  |  BMJ OPEN

Life satisfaction, QALYs, and the monetary value of health

Li Huang, Paul Frijters, Kim Dalziel, Philip Clarke

Journal article  |  2018  |  Social Science & Medicine

Uptake of and Expenditure on Direct-Acting Antiviral Agents for Hepatitis C Treatment in Australia

Barbara de Graaff, Kwang Chien Yee, Philip Clarke, Andrew Palmer

Journal article  |  2018  |  Applied Health Economics and Health Policy

Born equal? The distribution of government Medicare spending for children

Kim M Dalziel, Li Huang, Harriet Hiscock, Philip M Clarke

Journal article  |  2018  |  Social Science & Medicine

Aspects of Multicomponent Integrated Care Promote Sustained Improvement in Surrogate Clinical Outcomes: A Systematic Review and Meta-analysis

Lee Ling Lim, Eric SH Lau, Alice PS Kong, Melanie J Davies, Naomi S Levitt, Bjorn Eliasson, Carlos A Aguilar-Salinas, Guang Ning, Yutaka Seino, Wing Yee So, Margaret McGill, Graham D Ogle, Trevor J Orchard, Philip Clarke, Rury R Holman, Edward W Gregg, Juan Jose Gagliardino, Juliana CN Chan

Journal article  |  2018  |  Diabetes Care

Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge

Andrew J Palmer, Lei Si, Michelle Tew, Xinyang Hua, Michael S Willis, Christian Asseburg, Phil McEwan, Jose Leal, Alastair Gray, Volker Foos, Mark Lamotte, Talitha Feenstra, Patrick J O'Connor, Michael Brandle, Harry J Smolen, James C Gahn, William J Valentine, Richard F Pollock, Penny Breeze, Alan Brennan, et al.

Journal article  |  2018  |  VALUE IN HEALTH

Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol

Sybil A McAuley, Martin de Bock, Vijaya Sundararajan, Melissa H Lee, Barbora Paldus, Geoff R Ambler, Leon A Bach, Morton G Burt, Fergus J Cameron, Philip M Clarke, Neale D Cohen, Peter G Colman, Elizabeth A Davis, Jan M Fairchild, Christel Hendrieckx, D Jane Holmes-Walker, Jodie C Horsburgh, Alicia J Jenkins, Joey Kaye, Anthony C Keech, et al.

Journal article  |  2018  |  BMJ Open

Longevity of outstanding sporting achievers: Mind versus muscle

An Tran-Duy, David C Smerdon, Philip M Clarke

Journal article  |  2018  |  PLOS ONE

A TALE OF TWO UNIVERSAL HEALTH INSURANCE SCHEMES IN ONE COUNTRY: HORIZONTAL INEQUALITY OF GOVERNMENT MEDICAL AND PHARMACEUTICAL BENEFITS FOR AUSTRALIAN CHILDREN

L Huang, P Clarke, K Dalziel

Conference Proceedings  |  2018  |  Value in Health

Treatment gaps and potential cardiovascular risk reduction from expanded statin use in the US and England

Peter Ueda, Thomas Wai-Chun Lung, Yuan Lu, Joshua A Salomon, Kazem Rahimi, Philip Clarke, Goodarz Danaei

Journal article  |  2018  |  PLOS ONE

Subgroup Decomposability of Income-Related Inequality of Health, with an Application to Australia

Guido Erreygers, Roselinde Kessels, Linkun Chen, Philip Clarke

Journal article  |  2018  |  Economic Record

Individualized Glycemic Control for U. S. Adults With Type 2 Diabetes A Cost-Effectiveness Analysis

Neda Laiteerapong, Jennifer M Cooper, M Reza Skandari, Philip M Clarke, Aaron N Winn, Rochelle N Naylor, Elbert S Huang

Journal article  |  2018  |  Annals of Internal Medicine

The Impact of Regression to the Mean on Economic Evaluation in Quasi-Experimental Pre-Post Studies: The Example of Total Knee Replacement Using Data from the Osteoarthritis Initiative

Chris Schilling, Dennis Petrie, Michelle M Dowsey, Peter F Choong, Philip Clarke

Journal article  |  2017  |  Health Economics

Australian general practitioners initiate statin therapy primarily on the basis of lipid levels; New Zealand general practitioners use absolute risk

Chris Schilling, Josh Knight, Duncan Mortimer, Dennis Petrie, Philip Clarke, John Chalmers, Andrew Kerr, Rod Jackson

Journal article  |  2017  |  HEALTH POLICY

Cost-effectiveness of artemisinin-naphthoquine versus artemether-lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children

Brioni R Moore, Wendy A Davis, Philip M Clarke, Leanne J Robinson, Moses Laman, Timothy ME Davis

Journal article  |  2017  |  Malaria Journal

Validation and recalibration of the Framingham cardiovascular disease risk models in an Australian Indigenous cohort

Xinyang Hua, Robyn McDermott, Thomas Lung, Mark Wenitong, An Tran-Duy, Ming Li, Philip Clarke

Journal article  |  2017  |  EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY

Application of the 2014 NICE cholesterol guidelines in the English population

Peter Ueda, Thomas Wai-Chun Lung, Philip Clarke, Goodarz Danaei

Journal article  |  2017  |  BRITISH JOURNAL OF GENERAL PRACTICE

Treatment gaps and potential cardiovascular risk reduction from expanded statin use in the US and England

P Ueda, TWC Lung, Y Lu, J Salomon, K Rahimi, P Clarke, G Danaei

Conference Proceedings  |  2017  |  EUROPEAN HEART JOURNAL

Cost-effectiveness of gastric band surgery for overweight but not obese adults with type 2 diabetes in the US

John M Wentworth, Kim M Dalziel, Paul E O'Brien, Paul Burton, Frackson Shaba, Philip M Clarke, Neda Laiteerapong, Wendy A Brown

Journal article  |  2017  |  Journal of Diabetes and its Complications

Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial

Joel Gummer, Robert Trengove, Elaine M Pascoe, Sunil V Badve, Alan Cass, Philip Clarke, Stephen P McDonald, Alicia T Morrish, Eugenie Pedagogos, Vlado Perkovic, Donna Reidlinger, Anish Scaria, Rowan Walker, Liza A Vergara, Carmel M Hawley, David W Johnson, John K Olynyk, Paolo Ferrari

Journal article  |  2017  |  NEPHROLOGY

On the measurement of socioeconomic inequality of health between countries

Guido Erreygers, Philip Clarke, Qiong Zheng

Journal article  |  2017  |  JOURNAL OF ECONOMIC INEQUALITY

Coal mine dust lung disease in the modern era

Jennifer L Perret, Brian Plush, Philippe Lachapelle, Timothy SC Hinks, Clare Walter, Philip Clarke, Louis Irving, Pat Brady, Shyamali C Dharmage, Alastair Stewart

Journal article  |  2017  |  RESPIROLOGY

Using administrative data to look at changes in the level and distribution of out-of-pocket medical expenditure: An example using Medicare data from Australia

Xinyang Hua, Guido Erreygers, John Chalmers, Tracey-Lea Laba, Philip Clarke

Journal article  |  2017  |  Health Policy

How Consistent is the Relationship between Improved Glucose Control and Modelled Health Outcomes for People with Type 2 Diabetes Mellitus? a Systematic Review

Xinyang Hua, Thomas Wai-Chun Lung, Andrew Palmer, Lei Si, William H Herman, Philip Clarke

Journal article  |  2017  |  PHARMACOECONOMICS

Time to publication for publicly funded clinical trials in Australia: an observational study

Linn Beate Strand, Philip Clarke, Nicholas Graves, Adrian G Barnett

Journal article  |  2017  |  BMJ OPEN

Predicting the Long-Term Gains in Health-Related Quality of Life After Total Knee Arthroplasty

Chris G Schilling, Michelle M Dowsey, Dennis J Petrie, Philip M Clarke, Peter F Choong

Journal article  |  2017  |  The Journal of Arthroplasty

Damned lies, statistics and Medicare

G Erreygers, P Clarke, X Hua

Journal article  |  2017  |  https://croakey.org/damned-lies-statistics-and-medicare/

Using democracy to award research funding: an observational study.

Adrian G Barnett, Philip Clarke, Cedryck Vaquette, Nicholas Graves

Journal article  |  2017  |  Res Integr Peer Rev

Background: Winning funding for health and medical research usually involves a lengthy application process. With success rates und..

The association between maternal size and outcomes for women undergoing for caesarean section: a multicentre prospective observational study (The MUM SIZE Study)

A DENNIS, M Tew, K Dalziel, P Clarke, J Lew, D Story, A Parker, E Hessian, G Teale, S Simmons, D Casalaz

Journal article  |  2017  |  BMJ Open

Growth of linked hospital data use in Australia: a systematic review

Michelle Tew, Kim M Dalziel, Dennis J Petrie, Philip M Clarke

Journal article  |  2017  |  AUSTRALIAN HEALTH REVIEW

Revisiting the "Christmas Holiday Effect" in the Southern Hemisphere

Josh Knight, Chris Schilling, Adrian Barnett, Rod Jackson, Phillip Clarke

Journal article  |  2016  |  JOURNAL OF THE AMERICAN HEART ASSOCIATION

Using Patient-Reported Outcomes for Economic Evaluation: Getting the Timing Right

Chris Schilling, Michelle M Dowsey, Philip M Clarke, Peter F Choong

Journal article  |  2016  |  Value in Health

Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report

Sorrel E Wolowacz, Andrew Briggs, Vasily Belozeroff, Philip Clarke, Lynda Doward, Ron Goeree, Andrew Lloyd, Richard Norman

Journal article  |  2016  |  Value in Health

Cost of Antihyperglycemic Medications in the United States Reply

Xinyang Hua, William H Herman, Philip Clarke

Journal article  |  2016  |  JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A randomized-controlled trial of high- or low-volume intravenous Plasma-Lyte((R)) to prevent hypotension during sedation for colonoscopy

Kate Leslie, Megan Allen, Austin Lee, Phillip Clarke

Journal article  |  2016  |  Canadian Journal of Anesthesia/Journal canadien d'anesthésie

Do Model-Based Studies in Chronic Obstructive Pulmonary Disease Measure Correct Values of Utility? A Meta-Analysis

Foruhar Moayeri, Ya-Seng Arthur Hsueh, Philip Clarke, David Dunt

Journal article  |  2016  |  Value in Health

Recent trends in life expectancy for people with type 1 diabetes in Sweden

Dennis Petrie, Tom WC Lung, Aidin Rawshani, Andrew J Palmer, Ann-Marie Svensson, Bjorn Eliasson, Philip Clarke

Journal article  |  2016  |  DIABETOLOGIA

Alexander Sutherland: A Forgotten Pioneer of Health Economics in Australia?

Philip Clarke, Guido Erreygers

Journal article  |  2016  |  AUSTRALIAN ECONOMIC REVIEW

Expenditures and Prices of Antihyperglycemic Medications in the United States: 2002-2013

Xinyang Hua, Natalie Carvalho, Michelle Tew, Elbert S Huang, William H Herman, Philip Clarke

Journal article  |  2016  |  JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Decision-making in an era of cancer prevention via aspirin: New Zealand needs updated guidelines and risk calculators

Nick Wilson, Vanessa Selak, Tony Blakely, Josh Knight, Nhung Nghiem, William Leung, Philip Clarke, Rod Jackson

Journal article  |  2016  |  NEW ZEALAND MEDICAL JOURNAL

Cost-effectiveness of screening for anal cancer using regular digital ano-rectal examinations in men who have sex with men living with HIV

Jason J Ong, Christopher K Fairley, Susan Carroll, Sandra Walker, Marcus Chen, Tim Read, Andrew Grulich, Catriona Bradshaw, John Kaldor, Philip Clarke

Journal article  |  2016  |  JOURNAL OF THE INTERNATIONAL AIDS SOCIETY

Using Classification and Regression Trees (CART) to Identify Prescribing Thresholds for Cardiovascular Disease

Chris Schilling, Duncan Mortimer, Kim Dalziel, Emma Heeley, John Chalmers, Philip Clarke

Journal article  |  2016  |  PHARMACOECONOMICS

The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial

Lei Zhang, Jeff Coombes, Elaine M Pascoe, Sunil V Badve, Kim Dalziel, Alan Cass, Philip Clarke, Paolo Ferrari, Stephen P McDonald, Alicia T Morrish, Eugenie Pedagogos, Vlado Perkovic, Donna Reidlinger, Anish Scaria, Rowan Walker, Liza A Vergara, Carmel M Hawley, David W Johnson

Journal article  |  2016  |  Redox Report

Changes in Quality of Life Associated with Complications of Diabetes: Results from the ADVANCE Study

Alison Hayes, Hisatomi Arima, Mark Woodward, John Chalmers, Neil Poulter, Pavel Hamet, Philip Clarke

Journal article  |  2016  |  Value in Health

A randomized trial of fellowships for early career researchers finds a high reliability in funding decisions

Philip Clarke, Danielle Herbert, Nick Graves, Adrian G Barnett

Journal article  |  2016  |  JOURNAL OF CLINICAL EPIDEMIOLOGY

Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling

Rafael Perera, Emily McFadden, Julie McLellan, Tom Lung, Philip Clarke, Teresa Perez, Thomas Fanshawe, Andrew Dalton, Andrew Farmer, Paul Glasziou, Osamu Takahashi, John Stevens, Les Irwig, Jennifer Hirst, Sarah Stevens, Asuka Leslie, Sachiko Ohde, Gautam Deshpande, Kevin Urayama, Brian Shine, et al.

Journal article  |  2015  |  HEALTH TECHNOLOGY ASSESSMENT

COST-EFFECTIVENESS OF SCREENING FOR ANAL CANCER USING REGULAR DIGITAL ANO-RECTAL EXAMINATIONS IN HIV-POSITIVE MEN WHO HAVE SEX WITH MEN

J Ong, CK Fairley, S Carroll, S Walker, M Chen, T Read, C Bradshaw, A Grulich, J Kaldor, P Clarke

Conference Proceedings  |  2015  |  SEXUALLY TRANSMITTED INFECTIONS

Estimating The Potential Impact Of Insurance Expansion On Undiagnosed And Uncontrolled Chronic Conditions

Daniel R Hogan, Goodarz Danaei, Majid Ezzati, Philip M Clarke, Ashish K Jha, Joshua A Salomon

Journal article  |  2015  |  HEALTH AFFAIRS

Survival of the fittest: retrospective cohort study of the longevity of Olympic medallists in the modern era

Philip M Clarke, Simon J Walter, Andrew Hayen, William J Mallon, Jeroen Heijmans, David M Studdert

Journal article  |  2015  |  British Journal of Sports Medicine

Measuring the Progressivity of the Pharmaceutical Benefits Scheme

Rachel J Knott, Philip M Clarke, Emma L Heeley, John P Chalmers

Journal article  |  2015  |  AUSTRALIAN ECONOMIC REVIEW

Long-term Disability Associated With War-related Experience Among Vietnam Veterans Retrospective Cohort Study

Philip M Clarke, Robert Gregory, Joshua A Salomon

Journal article  |  2015  |  MEDICAL CARE

The effects of reduced copayments on discontinuation and adherence failure to statin medication in Australia

Rachel J Knott, Dennis J Petrie, Emma L Heeley, John P Chalmers, Philip M Clarke

Journal article  |  2015  |  HEALTH POLICY

Patterns of Cancer Care Costs in a Country With Detailed Individual Data

Tony Blakely, June Atkinson, Giorgi Kvizhinadze, Nick Wilson, Anna Davies, Philip Clarke

Journal article  |  2015  |  MEDICAL CARE

Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial.

Sunil V Badve, Lei Zhang, Jeff S Coombes, Elaine M Pascoe, Alan Cass, Philip Clarke, Paolo Ferrari, Stephen P McDonald, Alicia T Morrish, Eugenie Pedagogos, Vlado Perkovic, Donna Reidlinger, Anish Scaria, Rowan Walker, Liza A Vergara, Carmel M Hawley, David W Johnson, undefined HERO Study Collaborative Group

Journal article  |  2015  |  Can J Kidney Health Dis

BACKGROUND: Erythropoiesis stimulating agent (ESA)-resistant anemia is common in chronic kidney disease (CKD). OBJECTIVES: To eval..

Income Contingent Collection of a 'Brain Drain Tax': Theory, Policy and Empirical Potential

Bruce Chapman, Philip Clarke, Timothy Higgins, Miranda Stewart

Journal article  |  2015  |  Population Review

Health State Utility Value in Chronic Obstructive Pulmonary Disease (COPD); The Challenge of Heterogeneity: A Systematic Review and Meta-Analysis

F Moayeri, Y Hsueh,, P Clarke,, X Hua,, undefined Dunt

Journal article  |  2015  |  COPD: Journal of Chronic Obstructive Pulmonary Disease

The impact of a streamlined funding application process on application time: two cross-sectional surveys of Australian researchers

Adrian G Barnett, Nicholas Graves, Philip Clarke, Danielle Herbert

Journal article  |  2015  |  BMJ OPEN

Using simplified peer review processes to fund research: a prospective study

Danielle L Herbert, Nicholas Graves, Philip Clarke, Adrian G Barnett

Journal article  |  2015  |  BMJ OPEN

A Randomized, Placebo-Controlled Trial of Pentoxifylline on Erythropoiesis-Stimulating Agent Hyporesponsiveness in Anemic Patients With CKD: The Handling Erythropoietin Resistance With Oxpentifylline (HERO) Trial

David W Johnson, Elaine M Pascoe, Sunil V Badve, Kim Dalziel, Alan Cass, Philip Clarke, Paolo Ferrari, Stephen P McDonald, Alicia T Morrish, Eugenie Pedagogos, Vlado Perkovic, Donna Reidlinger, Anish Scaria, Rowan Walker, Liza A Vergara, Carmel M Hawley

Journal article  |  2015  |  American Journal of Kidney Diseases

Performance of the UKPDS Outcomes Model for Prediction of Myocardial Infarction and Stroke in the ADDITION-Europe Trial Cohort: Does the ADDITION Validation Add Up?

Alastair Gray, Rury Holman, Philip Clarke, Jose Leal

Journal article  |  2014  |  Value in Health

A Meta-Analysis of the Relative Risk of Mortality for Type 1 Diabetes Patients Compared to the General Population: Exploring Temporal Changes in Relative Mortality

Tom WC Lung, Alison J Hayes, William H Herman, Lei Si, Andrew J Palmer, Philip M Clarke

Journal article  |  2014  |  PLOS ONE

Severe Hypoglycemia and Mortality After Cardiovascular Events for Type 1 Diabetic Patients in Sweden

Tom WC Lung, Dennis Petrie, William H Herman, Andrew J Palmer, Ann-Marie Svensson, Bjorn Eliasson, Philip M Clarke

Journal article  |  2014  |  DIABETES CARE

Pharmaceuticals, Pharmacists and profits: A health policy perspective

P Clarke

Journal article  |  2014  |  Australian Prescriber

Predicting mortality in people with Type 2 diabetes mellitus after major complications: a study using Swedish National Diabetes Register data

PJ Kelly, PM Clarke, AJ Hayes, U-G Gerdtham, J Cederholm, P Nilsson, B Eliasson, S Gudbjornsdottir

Journal article  |  2014  |  Diabetic Medicine

A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF PENTOXIFYLLINE ON ERYTHROPOIESIS STIMULATING AGENT RESISTANCE IN ANAEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE - THE HERO TRIAL

DW Johnson, E Pascoe, SV Badve, K Dalziel, A Cass, P Clarke, P Ferrari, SP Mcdonald, AT Morrish, E Pedagogos, V Perkovic, A Scaria, R Walker, LA Vergara, CM Hawley

Journal article  |  2014  |  NEPHROLOGY

ASSOCIATION BETWEEN SERUM ALKALINE PHOSPHATASE AND RESISTANCE TO ERYTHROPOIESIS STIMULATING AGENTS IN CHRONIC KIDNEY DISEASE: A POST-HOC ANALYSIS OF THE HERO TRIAL

SV Badve, EM Pascoe, A Cass, P Clarke, J Coombes, P Ferrari, SP Mcdonald, AT Morrish, E Pedagogos, V Perkovic, D Reidlinger, A Scaria, R Walker, LA Vergara, CM Hawley, DW Johnson

Journal article  |  2014  |  Nephrology

Severe Hypoglycaemia and All-Cause Mortality in Swedish Type 1 Diabetes Patients

Tom Lung, Philip M Clarke, Dennis Petrie, Ann-Marie Svensson, Andrew J Palmer, William H Herman, Bjorn Eliasson

Conference Proceedings  |  2014  |  DIABETES

Trends in Life Expectancy for Those with Type 1 Diabetes in Sweden

Dennis J Petrie, Philip M Clarke, Thomas Lung, Andrew J Palmer, Ann-Marie Svensson, Bjorn Eliasson

Conference Proceedings  |  2014  |  DIABETES

Evaluating the costs and benefits of using combination therapies

Philip M Clarke, Alex B Avery

Journal article  |  2014  |  Medical Journal of Australia

Forgetting to remember or remembering to forget: A study of the recall period length in health care survey questions

Gustav Kjellsson, Philip Clarke, Ulf-G Gerdtham

Journal article  |  2014  |  JOURNAL OF HEALTH ECONOMICS

THE EFFECT OF DIABETES COMPLICATIONS ON HEALTH-RELATED QUALITY OF LIFE: THE IMPORTANCE OF LONGITUDINAL DATA TO ADDRESS PATIENT HETEROGENEITY

Maria Alva, Alastair Gray, Borislava Mihaylova, Philip Clarke

Journal article  |  2014  |  Health Economics

Optimal strategies for identifying kidney disease in diabetes: properties of screening tests, progression of renal dysfunction and impact of treatment - systematic review and modelling of progression and cost-effectiveness

Andrew J Farmer, Richard Stevens, Jennifer Hirst, Tom Lung, Jason Oke, Philip Clarke, Paul Glasziou, Andrew Neil, David Dunger, Helen M Colhoun, Christopher Pugh, Germain Wong, Rafael Perera, Brian Shine

Journal article  |  2014  |  Health Technology Assessment

Measuring Equality and Equity in Health and Health Care

T Van Ourti, G Erreygers, P Clarke

Book Chapter  |  2014

The impact of funding deadlines on personal workloads, stress and family relationships: a qualitative study of Australian researchers

Danielle L Herbert, John Coveney, Philip Clarke, Nicholas Graves, Adrian G Barnett

Journal article  |  2014  |  BMJ OPEN

UKPDS Outcomes Model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82

AJ Hayes, J Leal, AM Gray, RR Holman, PM Clarke

Journal article  |  2013  |  DIABETOLOGIA

The effects of patient characteristics and geographical region on hospitalization in patients with Type 2 diabetes

MJ Zaman, A Patel, J Chalmers, M Woodward, P Clarke, Q Li, S Zoungas

Journal article  |  2013  |  Diabetic Medicine

Adapting and validating diabetes simulation models across settings: Accounting for mortality differences using administrative data

Alison J Hayes, Wendy A Davis, Timothy M Davis, Philip M Clarke

Journal article  |  2013  |  Journal of Diabetes and its Complications

Temporal Validation of the UKPDS Outcomes Model Using 10-Year Posttrial Monitoring Data

Jose Leal, Alison J Hayes, Alastair M Gray, Rury R Holman, Philip M Clarke

Journal article  |  2013  |  DIABETES CARE

Computer modeling of diabetes and its complications: a report on the Fifth Mount Hood challenge meeting.

Andrew J Palmer, undefined Mount Hood 5 Modeling Group, Philip Clarke, Alastair Gray, Jose Leal, Adam Lloyd, David Grant, James Palmer, Volker Foos, Mark Lamotte, William Hermann, Jacob Barhak, Michael Willis, Ruth Coleman, Ping Zhang, Phil McEwan, Jonathan Betz Brown, Ulf Gerdtham, Elbert Huang, Andrew Briggs, et al.

Journal article  |  2013  |  Value in Health

OBJECTIVES: The Mount Hood Challenge meetings provide a forum for computer modelers of diabetes to discuss and compare models, to ..

The pricing of statins and implications for Pharmaceutical Benefits Scheme expenditure

Philip M Clarke

Journal article  |  2013  |  Medical Journal of Australia

On the time spent preparing grant proposals: an observational study of Australian researchers

Danielle L Herbert, Adrian G Barnett, Philip Clarke, Nicholas Graves

Journal article  |  2013  |  BMJ Open

Predicting Changes in Cardiovascular Risk Factors in Type 2 Diabetes in the Post-UKPDS Era: Longitudinal Analysis of the Swedish National Diabetes Register

Aliasghar Ahmad Kiadaliri, Philip M Clarke, Ulf-G Gerdtham, Peter Nilsson, Bjorn Eliasson, Soffia Gudbjornsdottir, Katarina Steen Carlsson

Journal article  |  2013  |  Journal of Diabetes Research

Simulating Lifetime Outcomes Associated with Complications for People with Type 1 Diabetes

Tom WC Lung, Philip M Clarke, Alison J Hayes, Richard J Stevens, Andrew Farmer

Journal article  |  2013  |  PHARMACOECONOMICS

Survival of the fittest: retrospective cohort study of the longevity of Olympic medallists in the modern era

Philip M Clarke, Simon J Walter, Andrew Hayen, William J Mallon, Jeroen Heijmans, David M Studdert

Journal article  |  2012  |  British Medical Journal

How fair is Medicare? The income-related distribution of Medicare benefits with special focus on chronic care items

Rachel J Knott, Alan Cass, Emma L Heeley, John P Chalmers, David P Peiris, Philip M Clarke

Journal article  |  2012  |  Medical Journal of Australia

Intergen 10: Clarifying the Crystal Ball

Anthony Scott, Deborah Cobb-Clark, Philip Clarke

Journal article  |  2012  |  Australian Economic Review

ADAPTING AND VALIDATING DIABETES SIMULATION MODELS ACROSS SETTINGS: ACCOUNTING FOR MORTALITY DIFFERENCES USING ADMINISTRATIVE DATA FROM AUSTRALIA

AJ Hayes, PM Clarke, W Davis

Conference Proceedings  |  2012  |  Value in Health

Challenges and opportunities for the Pharmaceutical Benefits Scheme

Philip M Clarke

Journal article  |  2012  |  Medical Journal of Australia

"Mirror, mirror, on the wall, who in this land is fairest of all?" Distributional sensitivity in the measurement of socioeconomic inequality of health

Guido Erreygers, Philip Clarke, Tom Van Ourti

Journal article  |  2012  |  Journal of Health Economics

A meta-analysis of health state valuations for people with diabetes: explaining the variation across methods and implications for economic evaluation

Tom WC Lung, Alison J Hayes, Andrew Hayen, Andrew Farmer, Philip M Clarke

Journal article  |  2011  |  Quality of Life Research

PARAMETRIC CONDITIONAL NON-FRAILTY MODEL FOR RECURRENT EVENTS IN PERSONS WITH TYPE 2 DIABETES IN SWEDEN: THE EXAMPLE OF MYOCARDIAL INFARCTION

Ahmad A Kiadaliri, PM Clarke, UG Gerdtham, P Nilsson, B Eliasson, S Gudbjornsdottir, Steen K Carlsson

Conference Proceedings  |  2011  |  VALUE IN HEALTH

Comparability of Patient-reported Health Status Multicountry Analysis of EQ-5D Responses in Patients With Type 2 Diabetes

Joshua A Salomon, Anushka Patel, Bruce Neal, Paul Glasziou, Diederick E Grobbee, John Chalmers, Philip M Clarke

Journal article  |  2011  |  Medical Care

Funding grant proposals for scientific research: retrospective analysis of scores by members of grant review panel

Nicholas Graves, Adrian G Barnett, Philip Clarke

Journal article  |  2011  |  British Medical Journal

Change in bias in self-reported body mass index in Australia between 1995 and 2008 and the evaluation of correction equations

Alison J Hayes, Philip M Clarke, Tom WC Lung

Journal article  |  2011  |  Population Health Metrics

Death, Dollars and Degrees: Socio-economic Status and Longevity in Australia*

Philip Clarke, Andrew Leigh

Journal article  |  2011  |  Economic Papers

An improved model to estimate lifetime health outcomes of patients with type 2 diabetes using 30-year follow-up data from the United Kingdom prospective diabetes study

AJ Hayes, P Clarke, J Leal, ML Alva, R Coleman, A Gray, RR Holman

Conference Proceedings  |  2011  |  DIABETOLOGIA

Predicting the mortality of people with type 2 diabetes mellitus following a major complication: a study using Swedish National Diabetes Register data

PJ Kelly, PM Clarke, AJ Hayes, UG Gerdtham, PM Nilsson, B Eliasson, J Cederholm, S Gudbjornsdottir

Conference Proceedings  |  2011  |  DIABETOLOGIA

Predicting changes in risk factors in type 2 diabetes in the post-UKPDS era: longitudinal analysis of the Swedish national diabetes register

A Ahmad Kiadaliri, PM Clarke, UG Gerdtham, PM Nilsson, B Eliasson, S Gudbjornsdottir, K Steen Carlsson

Conference Proceedings  |  2011  |  DIABETOLOGIA

A SIMPLE CORRECTION TO REMOVE THE BIAS OF THE GINI COEFFICIENT DUE TO GROUPING

Tom Van Ourti, Philip Clarke

Journal article  |  2011  |  The Review of Economics and Statistics

Simulation of Quality-Adjusted Survival in Chronic Diseases: An Application in Type 2 Diabetes

Alison J Hayes, Philip M Clarke, Merryn Voysey, Anthony Keech

Journal article  |  2011  |  Medical Decision Making

Changes in Inequalities of Access to Dental Care in Australia 1977-2005

Edmund Maurice FitzGerald, Michelle Cunich, Philip Miles Clarke

Journal article  |  2011  |  Australian Economic Review

Risk equations to predict life expectancy of people with Type 2 diabetes mellitus following major complications: a study from Western Australia

AJ Hayes, J Leal, CW Kelman, PM Clarke

Journal article  |  2011  |  Diabetic Medicine

Cost-effectiveness of artemisinin combination therapy for uncomplicated malaria in children: data from Papua New Guinea

Wendy A Davis, Philip M Clarke, Peter M Siba, Harin A Karunajeewa, Carol Davy, Ivo Mueller, Timothy ME Davis

Journal article  |  2011  |  Bulletin of the World Health Organization

Cutting random funding decisions

Nicholas Graves, Adrian G Barnett, Philip Clarke

Journal article  |  2011  |  Nature

Expiry of patent protection on statins: effects on pharmaceutical expenditure in Australia REPLY

Philip M Clarke, Edmund M Fitzgerald

Journal article  |  2011  |  MEDICAL JOURNAL OF AUSTRALIA

In reply

PM Clarke, EM Fitzgerald

Journal article  |  2011  |  Medical Journal of Australia

COST-EFFECTIVENESS OF BLOOD PRESSURE LOWERING WITH A FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE IN TYPE 2 DIABETES MELLITUS: A TRIAL-BASED ANALYSIS USING THE ADVANCE STUDY

PM Clarke, P Glasziou, J Alexander, J Chalmers, A Patel

Journal article  |  2010  |  Value in Health

Cost-effectiveness of lowering blood pressure with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: an ADVANCE trial-based analysis

Paul P Glasziou, Philip Clarke, Jan Alexander, Mohana Rajmokan, Elaine Beller, Mark Woodward, John Chalmers, Neil Poulter, Anushka Patel

Journal article  |  2010  |  Medical Journal of Australia

Estimating the quality of life impact of diabetes related complications: new results from the UKPDS

ML Alva, A Gray, B Mihaylova, P Clarke

Conference Proceedings  |  2010  |  DIABETOLOGIA

Expiry of patent protection on statins: effects on pharmaceutical expenditure in Australia REPLY

Philip M Clarke, Edmund M FitzGerald

Journal article  |  2010  |  Medical Journal of Australia

Expiry of patent protection on statins: effects on pharmaceutical expenditure in Australia

Philip M Clarke, Edmund M Fitzgerald

Journal article  |  2010  |  Medical Journal of Australia

Life Expectancy in Individuals With Type 2 Diabetes: Implications for Annuities

Hermione C Price, Philip M Clarke, Alastair M Gray, Rury R Holman

Journal article  |  2010  |  Medical Decision Making

DOES INCOME-RELATED HEALTH INEQUALITY CHANGE AS THE POPULATION AGES? EVIDENCE FROM SWEDISH PANEL DATA

M Kamrul Islam, Ulf-G Gerdtham, Philip Clarke, Kristina Burstrom

Journal article  |  2010  |  Health Economics

Event Rates, Hospital Utilization, and Costs Associated with Major Complications of Diabetes: A Multicountry Comparative Analysis

Philip M Clarke, Paul Glasziou, Anushka Patel, John Chalmers, Mark Woodward, Stephen B Harrap, Joshua A Salomon

Journal article  |  2010  |  PLoS Medicine

Calculating the concentration index when income is grouped

Philip Clarke, Tom Van Ourti

Journal article  |  2010  |  Journal of Health Economics

Development of life-expectancy tables for people with type 2 diabetes

Jose Leal, Alastair M Gray, Philip M Clarke

Journal article  |  2009  |  European Heart Journal

Measuring achievement: Changes in risk factors for cardiovascular disease in Australia

Philip M Clarke, Alison J Hayes

Journal article  |  2009  |  Social Science & Medicine

Estimating the Cost of Diabetes Mellitus-Related Events from Inpatient Admissions in Sweden Using Administrative Hospitalization Data

Ulf-G Gerdtham, Philip Clarke, Alison Hayes, Soffia Gudbjornsdottir

Journal article  |  2009  |  Pharmacoeconomics

Using the EQ-5D Index Score as a Predictor of Outcomes in Patients With Type 2 Diabetes

Philip M Clarke, Alison J Hayes, Paul G Glasziou, Russell Scott, John Shnes, Anthony C Keech

Journal article  |  2009  |  Medical Care

Estimating equations to correct self-reported height and weight: implications for prevalence of overweight and obesity in Australia

Alison J Hayes, Michael A Kortt, Philip M Clarke, Jason D Brandrup

Journal article  |  2008  |  Australian and New Zealand Journal of Public Health

Optimal recall length in survey design

Philip M Clarke, Denzil G Fiebig, Ulf-G Gerdtham

Journal article  |  2008  |  Journal of Health Economics

The economic analyses of the UK prospective diabetes study

AM Gray, P Clarke

Journal article  |  2008  |  Diabetic Medicine

Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial

Judit Simon, Alastair Gray, Philip Clarke, Aisha Wade, Andrew Neil, Andrew Farmer

Journal article  |  2008  |  British Medical Journal

Horizontal inequities in Australia's mixed public/private health care system

Eddy Van Doorslaer, Philip Clarke, Elizabeth Savage, Jane Hall

Journal article  |  2008  |  Health Policy

Can self-rated health scores be used for risk prediction in patients with type 2 diabetes?

Alison J Hayes, Philip M Clarke, Paul G Glasziou, R John Simes, Paul L Drury, Anthony C Keech

Journal article  |  2008  |  Diabetes Care

Estimating the cost of complications of diabetes in Australia using administrative health-care data

Philip Clarke, Jose Leal, Chris Kelman, Merran Smith, Stephen Colagiuri

Journal article  |  2008  |  Value in Health

Computer modeling of diabetes and its complications - A report on the Fourth Mount Hood Challenge Meeting

Andrew J Palmer, Stephane Roze, William J Valentine, Philip McEwan, Michael Gillett, Michael Holmes, Philip Clarke, Richard Stevens, Alastair M Gray, Ruth Coleman, Stephen Sorensen, Elvira Mueller, Stefan Walzer, David M Eddy, Richard Kahn, Adrian Bagust, Jonathan Brown, Alan Brennan, Wiley Chan, Alan Russell, et al.

Journal article  |  2007  |  Diabetes Care

Which health-related quality of life score ? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial

Paul Glasziou, Jan Alexander, Elaine Beller, Philip Clarke

Journal article  |  2007  |  Health and Quality of Life Outcomes

Pharmacy diabetes care program: Analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy

I Krass, B Mitchell, P Clarke, M Brillant, R Dienaar, J Hughes, P Lau, G Peterson, K Stewart, S Taylor, J Wilkinson, C Armour

Journal article  |  2007  |  Diabetes Research and Clinical Practice

Long-term cost-utility analysis of a multidisciplinary primary care diabetes management program in Ontario

D O'Reilly, R Hopkins, G Blackhouse, P Clarke, J Hux, JE Tarride, L Dolovich, R Goeree

Journal article  |  2007  |  Canadian Journal of Diabetes

Factors influencing the cost of hospital care for people with diabetes in Australia

Philip Clarke, Chris Kelman, Stephen Colagiuri

Journal article  |  2006  |  Journal of Diabetes and its Complications

End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong diabetes registry

XL Yang, WY So, APS Kong, P Clarke, CS Ho, CWK Lam, MHL Ng, RR Lyu, DD Yin, CC Chow, CS Cockram, PCY Tong, JCN Chan

Journal article  |  2006  |  Diabetologia

Assessing the impact of visual acuity on quality of life in individuals with type 2 diabetes using the short form-36

Philip M Clarke, Judit Simon, Carole A Cull, Rury R Holman

Journal article  |  2006  |  Diabetes Care

Self-reported health: reliability and consequences for health inequality measurement

PM Clarke, C Ryan

Journal article  |  2006  |  Health Economics

Estimating the association between SF-12 responses and EQ-5D utility values by response mapping

AM Gray, O Rivero-Arias, PM Clarke

Journal article  |  2006  |  Medical Decision Making

Estimating utility values for health states of overweight and obese individuals using the SF-36

MA Kortt, PM Clarke

Journal article  |  2005  |  Quality of Life Research

Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72)

PM Clarke, AM Gray, A Briggs, RJ Stevens, DR Matthews, RR Holman

Journal article  |  2005  |  Diabetologia

A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68)

PM Clarke, AM Gray, A Briggs, AJ Farmer, P Fenn, RJ Stevens, DR Matthews, IM Stratton, RR Holman

Journal article  |  2004  |  Diabetologia

Diabetes and associated major comorbidity accounts for 15% of total healthcare expenditure in Saskatchewan

S Simpson, P Corabian, P Jacobs, JA Johnson, PM Clarke, SM Smith

Journal article  |  2004  |  Evidence-based Healthcare

The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65)

P Clarke, A Gray, R Legood, A Briggs, R Holman

Journal article  |  2003  |  Diabetic Medicine

A note on the decomposition of the health concentration index

PM Clarke, UG Gerdtham, LB Connelly

Journal article  |  2003  |  Health Economics

Missing .... presumed at random: cost-analysis of incomplete data

A Briggs, T Clark, J Wolstenholme, P Clarke

Journal article  |  2003  |  Health Economics

New BMJ policy on economic evaluations [1] (multiple letters)

D Craig, J Nixon, N Armstrong, J Glanville, J Kleijnen, M Drummond, T Roberts, AM Gray, A Briggs, P Clarke, C Normand, CJ McCabe, J Roberts, R Smith

Journal article  |  2003  |  British Medical Journal

New BMJ policy on economic evaluations. Economic evaluations should be judged on scientific merit.

Alastair M Gray, Andrew Briggs, Philip Clarke

Journal article  |  2003  |  BMJ (Clinical research ed.)

New BMJ policy on economic evaluations - Response of NHS Economic Evaluation Database Research Team

D Craig, J Nixon, N Armstrong, J Glanville, J Kleijnen, M Drummond

Journal article  |  2003  |  BMJ

On the measurement of relative and absolute income-related health inequality

PM Clarke, UG Gerdtham, M Johannesson, K Bingefors, L Smith

Journal article  |  2002  |  Social Science & Medicine

Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63)

A Gray, P Clarke, A Farmer, R Holman

Journal article  |  2002  |  BMJ

Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62)

P Clarke, A Gray, R Holman

Journal article  |  2002  |  Medical Decision Making

Comparing health inequalities among men aged 18-65 years in Australia and England using the SF-36

P Clarke, L Smith, C Jenkinson

Journal article  |  2002  |  Australian and New Zealand Journal of Public Health

Testing the convergent validity of the contingent valuation and travel cost methods in valuing the benefits of health care

PM Clarke

Journal article  |  2002  |  Health Economics

An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54)

A Gray, P Clarke, M Raikou, A Adler, R Stevens, A Neil, C Cull, I Stratton, R Holman

Journal article  |  2001  |  Diabetic Medicine

Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with Type II diabetes (UKPDS No. 51)

P Clarke, A Gray, A Adler, R Stevens, M Raikou, C Cull, I Stratton, R Holman

Journal article  |  2001  |  Diabetologia

Valuing the benefits of mobile mammographic screening units using the contingent valuation method

PM Clarke

Journal article  |  2000  |  Applied Economics

More or less equal? Comparing Australian income-related inequality in self-reported health with other industrialised countries

P Clarke, L Smith

Journal article  |  2000  |  Australian and New Zealand Journal of Public Health

Cost-benefit analysis and mammographic screening: a travel cost approach

PM Clarke

Journal article  |  1998  |  Journal of Health Economics

General practitioner screening for melanoma: sensitivity, specificity, and effect of training

RC Burton, C Howe, L Adamson, AL Reid, P Hersey, A Watson, G Watt, J Relic, D Holt, V Thursfield, P Clarke, BK Armstrong

Journal article  |  1998  |  Journal of Medical Screening

Developing methodologies for evaluating community-wide health promotion

R SansonFisher, S Redman, L Hancock, S Halpin, P Clarke, M Schofield, R Burton, M Hensley, R Gibberd, A Reid, R Walsh, A Girgis, L Burton, A McClintock, R Carter, A Donner, S Green

Journal article  |  1996  |  Health Promotion International